AMO's lens solution linked to AK

Article

A "strong association" has been discovered between use of AMO''s Complete MoisturePlus Multi-Purpose Solution and an increased risk of Acanthamoeba keratitis (AK).

A "strong association" has been discovered between use of AMO's Complete MoisturePlus Multi-Purpose Solution and an increased risk of Acanthamoeba keratitis (AK).

Earlier this year, AMO voluntarily recalled the product and since then an investigation of 30 AK cases and 39 matched controls wearing soft contact lenses, found that those with AK infection were significantly more likely to have reported use of the AMO solution than those without the infection. The researchers, from the University of Illinois, Chicago, USA, found that users of the solution have a greater than 16-fold risk of developing AK.

The researchers, however, also made it clear that 39% of AK cases reported no use of AMO Complete MoisturePlus Multi-Purpose solution. Furthermore, the investigation also offered some evidence that re-using contact lens solution, rubbing lenses during cleaning and showering with lenses on also increases the risk of infection.

The FDA is concerned that, despite the solution being withdrawn from the market, consumers might still be using it. The governing body therefore urges soft contact lens wearers to throw away any partially used bottles.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.